肺静脉狭窄:解剖学考量、外科治疗与结局
该研究回顾性分析单中心肺静脉狭窄登记数据,纳入2007年1月至2019年8月174例接受肺静脉狭窄修复术的患者,中位年龄9个月。结果显示1年、2年、5年生存率分别为71.2%、66.8%、60.6%,解剖聚焦修复与死亡率降低相关(多变量HR 0.19,P=0.014),抗增殖化疗亦与死亡率降低相关(HR 0.47,P=0.026)。
要点
- 174例肺静脉狭窄修复术中,双侧病变111例(64%),4支血管病变71例(41%)。
- 术后2年累计经导管介入(球囊扩张±支架)发生率为64%。
- 解剖聚焦修复与死亡率降低相关(多变量HR 0.19,P=0.014)。
核心结论
- 该单中心大样本外科治疗肺静脉狭窄的经验显示令人鼓舞的中期结果,新解剖聚焦修复策略旨在减轻肺静脉成角以减少湍流,早期结局有前景,需继续随访以了解该术式的远期结局。
研究设计与样本
- 回顾性分析肺静脉狭窄登记数据,识别研究期间接受首次肺静脉狭窄修复术的患者,共174例。
主要发现
- 双侧肺静脉狭窄111例(64%),4支血管病变71例(41%),原发性肺静脉狭窄59例(34%)。
- 中位年龄9个月(四分位距5-27),体重6.5 kg(4.7-10.2)。
- 23例(13%)需再次手术,术后2年累计经导管介入(球囊扩张±支架)发生率为64%。
- 1年、2年、5年生存率分别为71.2%、66.8%、60.6%。
- 手术类型与再次手术率(HR 2.38,P=0.25)或经导管介入(HR 0.97,P=0.95)无关联。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The study objective was to evaluate outcomes of pulmonary vein stenosis repair in a large single-center cohort. METHODS: Clinical data from a pulmonary vein stenosis registry were retrospectively reviewed identifying patients who underwent pulmonary vein stenosis repair. The primary/index operation was defined as the patient's first pulmonary vein stenosis operation during the study period. RESULTS: Between January 2007 and August 2019, 174 patients underwent pulmonary vein stenosis repair. Bilateral pulmonary vein stenosis occurred in 111 patients (64%); 71 patients (41%) had 4-vessel disease. Fifty-nine patients (34%) had primary pulmonary vein stenosis. Median age was 9 months (interquartile range, 5-27) and weight was 6.5 kg (4.7-10.2). Surgical techniques evolved and included ostial resection, unroofing, reimplantation, sutureless, modified sutureless, and a newer anatomically focused approach of pulmonary vein stenosis resection with lateralization or patch enlargement of the pulmonary vein-left atrium connection. Twenty-three patients (13%) required reoperation. Cumulative 2-year incidence of postoperative transcatheter intervention (balloon dilation ± stenting) was 64%. One-, 2-, and 5-year survivals were 71.2%, 66.8%, and 60.6%, respectively. There was no association between surgery type and reoperation rate (hazard ratio, 2.38, P = .25) or transcatheter intervention (hazard ratio, 0.97, P = .95). The anatomically focused repair was associated with decreased mortality on univariate (hazard ratio, 0.38, P = .042) and multivariable analyses (hazard ratio, 0.19, P = .014). Antiproliferative chemotherapy was also associated with decreased mortality (hazard ratio, 0.47, P = .026). CONCLUSIONS: This large single-center surgical pulmonary vein stenosis experience demonstrates encouraging midterm results. A new anatomically focused repair strategy aims to alleviate pulmonary vein angulation to minimize turbulence and shows promising early outcomes. Continued follow-up is required to understand longer-term outcomes for this surgical approach.
引用
- Feins EN, Ireland C, Gauvreau K, et al. Pulmonary vein stenosis: Anatomic considerations, surgical management, and outcomes. J Thorac Cardiovasc Surg. 2021. PMID: 34801262. doi:10.1016/j.jtcvs.2021.10.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。